What will happen if there’s a government shutdown at day’s end

The U.S. federal government faces an imminent shutdown due to a congressional impasse over healthcare provisions in a short-term funding bill. While essential services will largely continue and furloughed federal workers will receive retroactive pay, agencies like HHS and Education will experience significant operational disruptions. Economically, Goldman Sachs projects a 0.15-0.2 percentage point weekly reduction in growth during a shutdown, though historical equity market reactions have been muted post-resolution. A key new development is the White House's Office of Management and Budget threatening "reduction-in-force" layoffs for some programs, indicating a potentially more aggressive impact than prior shutdowns.

Analysis

An imminent U.S. government shutdown is highly probable due to a legislative impasse over healthcare provisions in a short-term funding bill. While essential services such as Social Security, Medicare, and national security operations are expected to continue, significant operational disruptions are anticipated. The Department of Health and Human Services plans to furlough 41% of its staff, which will notably halt the FDA's acceptance of new drug and medical device applications that require user fees. Similarly, the Education Department will furlough 87% of its workforce, stopping civil rights investigations and new grant issuances. According to Goldman Sachs research, the economic impact is estimated to be a reduction in GDP growth of 0.15 to 0.2 percentage points per week, though this is expected to be recouped in the quarter following the government's reopening. Historically, equity markets have demonstrated resilience, with the last three prolonged shutdowns resulting in flat or positive market performance post-resolution. A key new risk factor is a White House memo threatening permanent "reduction-in-force" layoffs rather than temporary furloughs, indicating a potentially more severe and less predictable impact on federal agencies than in past events.

Key Decisions for Investors

• Given historical data showing muted long-term market reactions to shutdowns, investors should be cautious of overreacting to initial volatility, as precedent suggests a recovery is likely once a resolution is reached.
• Investors with exposure to the healthcare and biotech sectors should monitor the shutdown's duration, as the halt on new FDA drug and device application reviews could create approval backlogs and delay potential revenue streams for affected companies.
• The novel threat of permanent "reduction-in-force" layoffs, unlike past temporary furloughs, introduces a new tail risk; investors should watch for any execution of this policy, as it would signal a more severe disruption with less predictable economic consequences.
• While a short shutdown's estimated 0.2% weekly GDP impact is manageable, a protracted event extending for several weeks could increase macroeconomic uncertainty and warrant a more defensive portfolio posture.